RT Journal Article SR Electronic T1 Validation of a Computerized Cognitive Test Battery for Detection of Dementia and Mild Cognitive Impairment JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.11.10.20229369 DO 10.1101/2020.11.10.20229369 A1 Siao Ye A1 Kevin Sun A1 Duong Huynh A1 Huy Q. Phi A1 Brian Ko A1 Bin Huang A1 Reza Hosseini Ghomi YR 2022 UL http://medrxiv.org/content/early/2022/02/09/2020.11.10.20229369.abstract AB Background Early detection of dementia is critical for intervention and care planning but remains difficult. Computerized cognitive testing provides an accessible and promising solution to address these current challenges. This study evaluated a computerized cognitive testing battery (BrainCheck) for its diagnostic accuracy and ability to distinguish the severity of cognitive impairment.Methods 99 participants diagnosed with Dementia, Mild Cognitive Impairment (MCI), or Normal Cognition (NC) completed the BrainCheck battery. Statistical analyses compared participant performances on BrainCheck based on their diagnostic group.Results BrainCheck battery performance showed significant differences between the NC, MCI, and Dementia groups, achieving ≥88% sensitivity/specificity for separating NC from Dementia, and ≥77% sensitivity/specificity in separating the MCI group from NC/Dementia groups. Three-group classification found true positive rates ≥80% for the NC and Dementia groups and ≥64% for the MCI group.Conclusions BrainCheck was able to distinguish between diagnoses of Dementia, MCI, and NC, providing a potentially reliable tool for early detection of cognitive impairment.Competing Interest StatementThe following authors declare the following competing interests: BH, KS, RHG, SY, HP, BK report personal fees from BrainCheck, outside the submitted work; BH, RHG reports receiving stock options from BrainCheck.Funding StatementFunding was provided by BrainCheck, Inc.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approval was granted with the University of Washington Human Subjects Division under study ID: STUDY00000790 on August 1st, 2019.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData may be made available by contacting the corresponding author with a data use agreement. https://depts.washington.edu/mbwc/adrc/page/research-resources MCIMild Cognitive ImpairmentNCNormal CognitionMoCAMontreal Cognitive AssessmentSLUMSSaint Louis University Mental StatusMMSEMini-Mental State ExaminationNPTNeuropsychological TestingADAlzheimer’s DiseaseANOVAAnalysis of VarianceROCReceiver Operating CharacteristicAUCArea Under the CurveUWUniversity of Washington